Cardiff University, ranked 2nd for the impact of its research in the UK, and a top five UK university for research excellence, researches technological and biological aspects of drug and gene delivery, including transcutaneous, pulmonary and intestinal delivery, and crossing the blood brain barrier.
Cardiff University was ranked 2nd nationally for the impact of its research and was among the top five universities in the UK for research excellence.
Its School of Pharmacy and Pharmaceutical Sciences is one of the top UK schools of pharmacy, and it conducts research on the discovery, development and use of drugs in areas such as Alzheimer’s disease, Parkinson’s disease, cancer, diabetes and infectious diseases.
The School’s two broad research themes are: Drug Discovery, Pharmaceutical Sciences and Experimental Therapeutics (DDPSET); and Medicines Optimisation and Healthcare Outcomes (MOHO).
Research into technological and biological aspects of drug and gene delivery falls predominantly within the DDPSET theme, and includes transcutaneous, pulmonary and intestinal delivery, and methods for crossing the blood brain barrier.